DAFTAR PUSTAKA

1. Bagian Obstetri Ginekologi FK UNPAD. Penyakit Trofoblas Gestasional; Obstetri Patologi; 1983; 28-33. 2. Cunningham FG, Gant NF, Leveno KJ, et al. Gestational Trophoblastic Disease : Williams Obstetrics.21th ed. Conneticut, Appleton & Lange, 2002; 835-843. 3. Winkjosastro H. Mola Hidatidosa ;Ilmu Kebidanan. Edisi ke-3. Jakarta. Yayasan Bina Pustaka Sarwono Prawirohardjo; 1999 : Hal: 142, 339- 348. 4. Rustam Muchtar. Penyakit Trofoblas :Sinopsis Obstetri. Edisi 2, Jilid 1. Penerbit buku Kedokteran. EGC. Hal. 238-243. 5. Lurain JR. Gestational trophoblastic disease I: epidemiology, pathology,clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. American Journal of Obstetrics & Gynecology 2010: 531-539. 6. Ilancheran A. Optimal Treatment in Gestational Trophoblastic Disease. Ann Acad Med Singapore 1998; 27:698-704. 7. Syafii, Aprianti S, Hardjoeno . Kadar B-Hcg Penderita Mola Hidatidosa Sebelum Dan Sesudah Kuretase. Indonesian Journal Of Clinical Pathology And Medical Laboratory, Vol. 13, No. 1, Nov. 2006: 1-3. 8. Berkowitz RS, Goldstein DP, Marean AR, et al. Oral contraceptives and postmolar gestational trophoblastic disease. ObstetGynecol 1981;58:474-7. 9. Curry SL, Schlaerth JB, Kohorn EI, et al. Hormonal contraception and trophoblastic se-quelae after hydatidiform mole (a gynecologic oncology group study). Am J ObstetGynecol 1989;160:805-11. 10. Deicas RE, Miller DS, Rademaker AW, et al. The role of contraception in the development of postmolar gestational trophoblastic tumor. Obstet Gynecol 1991;78:221-6.

11. Moore LE. Hydatidiform Mole Follow-up. http://emedicine.medscape.com/article/254657-followup. 2013.

Available diakses 17

at Juli

12. Sebire NJ ,Seckl MJ. Clinical review: gestational trophoblastic disease: current management of hydatidiform mole. Bmj 2008; 337: 453-458. 13. Lurain JR. Gestational trophoblastic disease: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. American Journal of Obstetrics & Gynecology. 2010. 14. Hunter CL. Molar Pregnancy With False Negative -hCG Urine In The Emergency Department. West J Emerg Med 2011;12(2):213-15. 15. Cunningham FG, Leveno KJ, Bloom SL et al. Gestational Trophoblastic Disease, in William Obstetrics. 22nd . New York, Mc Graw Hill ; 2007 ; Chapter 11. 16. Society of Gynecologic oncologies, Diagnosis and treatment of gestational trophoblastic disease. In : ACOG practice buletin, Clinical management guidelines for obstetrician and gynecologists number 53, June 2004. 17. Berkowitz RS, Goldstein DP. Gestational Trophoblastic Disease. In: Berek, JS eds Berek and Novaks Gynecology. 14th ed.Philadelphia, PA: Lippincott, Wiliams, and Wilkins; 2007:1581-1603. 18. Butch AW. Dilution Protocol For Detection Of Hook effect/ Prozone Phenomenon (Letter To The Editor) Clin Chem. 2000; 46:1719-20. 19. Davison CM, Kaplan RM, Wenig LN, Burmeister D. Qualitative beta-hCG urine assays may be misleading in the presence of molar pregnancy: A case report. J Emerg Med 2004;27:43-7. 20. Er TK, Jong YJ, Tsai EM, Huang CL, Chou HW, Zheng BH, et al. Falsenegative pregnancy test in hydatidiform mole. Clin Chem 2006;52:1616-8. 21. Yadav Y K, Fatima U, Dogra S, Kaushik A. Beware of "hook effect" giving false negative pregnancy test on point-of-care kits. J Postgrad Med 2013;59:153-4.

22. Berry E, Hagopian GS, Lurain JR.Vaginal. Metastases in gestational trophoblastic neoplasia. J Reprod Med. 2008;53:487-92. 23. H Alan, De Cherney, Nathan L. Gestational Trophoblastic Disease. In : Current Obstetric Gynecologic Diagnose and Treatment. 10th ed. Lange. Baltimore NY. Mc Graw Hill. 2007; Chapter 53. 24. Baergen RN,Rutgers JL,Young RH,etal. Placental site trophoblastic tumor:a study of 55 Cases and review of the literature emphasizing factors of prognostic significance.Gynecol Oncol2006;100:511-20. 25. AllisonKH,LoveJE,GarciaRL.Epithelioid Trophoblastic Tumor: review of a rare neoplasm Of the chorionic-type intermediate trophoblast. Arch Pathol Lab Med2006;130:1875-7. 26. Erhan Y, Ozdemir N, Zekioglu O, Nart D, Ciris M. Breast carcinomas with horiocarcinomatous features: case reports and review of the literature. Breast J. 2002;8(4):2448. 27. Shukla R, Pooja B, Radhika S, Nijhawan R, Rajwanshi A. Fine-needle aspiration cytology of extramammary neoplasms metastatic to the breast. Diagn Cytopathol. 2005;32(4):1937. 28. Dresang, LT. A Molar Pregnancy Detected by Following Human ChorionicGonadotropin Levels after a First Trimester Loss. JABFP 2005. 29. Gaffield ME, Kapp N, Curtis KM. Combined oral contraceptive and intrauterine device use among women with gestational trophoblastic disease, Contraception,June 2009 (80); 363-371. 30. Parazzini F, et al. Oral contraceptives and risk of trophoblasticdisease. Contraception, June 2002 (65); 425-427. gestational